Literature DB >> 20429385

[Expression and relationship of EBV LMP1, COX-2 and VEGF-C in nasopharyngeal carcinoma].

Xiang Yi1, Anzhou Tang, Ying Qin, Wensheng Wen, Weimin Zhao.   

Abstract

OBJECTIVE: To evaluate the expression of vascular endothelial growth factor C (VEGF-C), Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1), cyclooxygenase-2 (COX-2) in nasopharyngeal carcinoma (NPC).
METHOD: LMP1, COX-2 and VEGF-C were detects by immunohistochemical staining for 57 case NPC tissue. RESULT: The positives rates of LMP1, COX-2 and VEGF-C detected by immunohistochemical staining were 49.1% (28/57), 75.4% (43/57) and 59.6% (34/57), respectively. The expression of LMP1, COX-2 and VEGF-C were correlated to each other in NPC (P < 0.05).
CONCLUSION: LMP1 and COX-2 may induce expression of VEGF-C directly or LMP1 induce expression of VEGF-C by induce COX-2 expression, may contribute to lymph metastasis and develop NPC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20429385

Source DB:  PubMed          Journal:  Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi        ISSN: 1001-1781


  3 in total

Review 1.  Role of Modulator of Inflammation Cyclooxygenase-2 in Gammaherpesvirus Mediated Tumorigenesis.

Authors:  Jaya Gandhi; Lohit Khera; Nivedita Gaur; Catherine Paul; Rajeev Kaul
Journal:  Front Microbiol       Date:  2017-03-28       Impact factor: 5.640

Review 2.  Cyclooxygenase-2 expression is positively associated with lymph node metastasis in nasopharyngeal carcinoma.

Authors:  Gui Yang; Qiaoling Deng; Wei Fan; Zheng Zhang; Peipei Xu; Shihui Tang; Ping Wang; Jun'e Wang; Mingxia Yu
Journal:  PLoS One       Date:  2017-03-16       Impact factor: 3.240

3.  Expression profiling of 21 biomolecules in locally advanced nasopharyngeal carcinomas of Caucasian patients.

Authors:  Dimitrios Krikelis; Mattheos Bobos; Georgia Karayannopoulou; Liliana Resiga; Sofia Chrysafi; Epaminontas Samantas; Dimitrios Andreopoulos; Vassilios Vassiliou; Elisabeta Ciuleanu; George Fountzilas
Journal:  BMC Clin Pathol       Date:  2013-01-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.